We are live on ! Find out more
IGC icon

IGC Pharma
IGC

5 hedge funds and large institutions have $276K invested in IGC Pharma in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 6 → 5 (-1)

24% less capital invested

Capital invested by funds: $363K → $276K (-$87K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$24.1K
2
Creative Planning
Creative Planning
Kansas
+$4.48K
3
U
UBS
Switzerland
+$1.64K
4
TRCT
Tower Research Capital (TRC)
New York
+$81

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
1
Wells Fargo
California
$229K – – –
Citadel Advisors
2
Citadel Advisors
Florida
$34K +$24.1K +27,736 +185%
Creative Planning
3
Creative Planning
Kansas
$11K +$4.48K +5,145 +57%
U
4
UBS
Switzerland
$2K +$1.64K +1,889 +187%
VKH
5
Virtu KCG Holdings
New York
– -$33K -31,671 Closed
TRCT
6
Tower Research Capital (TRC)
New York
– +$81 +93 +664%

IGC Hedge Fund Activity: Q1 2014 in Review

5 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q1 2014, worth a combined $276K — down 24% from $363K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of IGC and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.

The largest buyer was Citadel Advisors, adding an estimated $24.1K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $33K sold.

  • 5 institutional investors held IGC Pharma (IGC) as of Q1 2014, down from 6 in Q4 2013.
  • Funds reported $276K of IGC Pharma stock for Q1 2014, down 24% quarter-over-quarter.
  • 0 funds opened new IGC Pharma positions in Q1 2014 and 1 closed out, a net change of -1 holder.
  • The largest IGC Pharma buyer in Q1 2014 was Citadel Advisors, an estimated $24.1K added.
  • The largest IGC Pharma seller in Q1 2014 was Virtu KCG Holdings, an estimated $33K sold.

Based on aggregated 13F filings for Q1 2014.